Structural analysis of asparaginyl endopeptidase reveals the activation mechanism and a reversible intermediate maturation stage
2014-03
发表期刊CELL RESEARCH
ISSN1001-0602
卷号24期号:3页码:344-358
发表状态已发表
DOI10.1038/cr.2014.4
摘要Asparaginyl endopeptidase (AEP) is an endo/lysosomal cysteine endopeptidase with a preference for an asparagine residue at the P1 site and plays an important role in the maturation of toll-like receptors 3/7/9. AEP is known to undergo autoproteolytic maturation at acidic pH for catalytic activation. Here, we describe crystal structures of the AEP proenzyme and the mature forms of AEP. Structural comparisons between AEP and caspases revealed similarities in the composition of key residues and in the catalytic mechanism. Mutagenesis studies identified N44, R46, H150, E189, C191, S217/S218 and D233 as residues that are essential for the cleavage of the peptide substrate. During maturation, autoproteolytic cleavage of AEP's cap domain opens up access to the active site on the core domain. Unexpectedly, an intermediate autoproteolytic maturation stage was discovered at approximately pH 4.5 in which the partially activated AEP could be reversed back to its proenzyme form. This unique feature was confirmed by the crystal structure of AEPpH4.5 (AEP was matured at pH 4.5 and crystallized at pH 8.5), in which the broken peptide bonds were religated and the structure was transformed back to its proenzyme form. Additionally, the AEP inhibitor cystatin C could be digested by the fully activated AEP, but could not be digested by activated cathepsins. Thus, we demonstrate for the first time that cystatins may regulate the activity of AEP through substrate competition for the active site.
关键词asparaginyl endopeptidase autoproteolytic maturation crystal structure innate immunity
收录类别SCI ; CSCD
语种英语
资助项目National Natural Science Foundation of China[31330019] ; National Natural Science Foundation of China[31200559] ; National Natural Science Foundation of China[91313301] ; National Natural Science Foundation of China[31300613]
WOS研究方向Cell Biology
WOS类目Cell Biology
WOS记录号WOS:000332246500010
CSCD记录号CSCD:5093932
出版者INST BIOCHEMISTRY & CELL BIOLOGY
WOS关键词MAMMALIAN LEGUMAIN ; MACROMOLECULAR STRUCTURES ; CYSTEINE PROTEASES ; ANTIGEN ; EXPRESSION ; CLEAVAGE ; PROTEIN ; DIFFRACTION ; INHIBITION ; CYSTATINS
原始文献类型Article
引用统计
被引频次:84[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/1071
专题免疫化学研究所_特聘教授组_结构生物化学实验室
iHuman研究所
iHuman研究所_PI研究组_刘志杰组
iHuman研究所_PI研究组_程建军组
通讯作者Liu, Zhi-Jie
作者单位
1.Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China
2.ShanghaiTech Univ, iHuman Inst, Shanghai 201210, Peoples R China
3.Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA
4.Los Alamos Natl Lab, Div Phys, Los Alamos, NM 87545 USA
5.Tsinghua Univ, Dept Chem, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Minist Educ, Beijing 100084, Peoples R China
6.Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
第一作者单位iHuman研究所
通讯作者单位iHuman研究所
推荐引用方式
GB/T 7714
Zhao, Lixia,Hua, Tian,Crowley, Christopher,et al. Structural analysis of asparaginyl endopeptidase reveals the activation mechanism and a reversible intermediate maturation stage[J]. CELL RESEARCH,2014,24(3):344-358.
APA Zhao, Lixia.,Hua, Tian.,Crowley, Christopher.,Ru, Heng.,Ni, Xiangmin.,...&Liu, Zhi-Jie.(2014).Structural analysis of asparaginyl endopeptidase reveals the activation mechanism and a reversible intermediate maturation stage.CELL RESEARCH,24(3),344-358.
MLA Zhao, Lixia,et al."Structural analysis of asparaginyl endopeptidase reveals the activation mechanism and a reversible intermediate maturation stage".CELL RESEARCH 24.3(2014):344-358.
条目包含的文件 下载所有文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Zhao, Lixia]的文章
[Hua, Tian]的文章
[Crowley, Christopher]的文章
百度学术
百度学术中相似的文章
[Zhao, Lixia]的文章
[Hua, Tian]的文章
[Crowley, Christopher]的文章
必应学术
必应学术中相似的文章
[Zhao, Lixia]的文章
[Hua, Tian]的文章
[Crowley, Christopher]的文章
相关权益政策
暂无数据
收藏/分享
文件名: 10.1038@cr.2014.4.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。